Skip to content

AARD AARD Current ratio

Current ratio at other companies

AbbVie logo
AbbVieABBV
0.8×0.0×
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
18.3×+13.0×
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
4.2×+0.9×
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
4.1×-0.8×
Viking Therapeutics logo
Viking TherapeuticsVKTX
5.7×-38.5×
Arvinas logo
ArvinasARVN
5.4×+0.9×

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×

Where this comes from

Calculated from AARD’s reported figures.

Based on the most recent quarter.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's current ratio?
AARD (AARD) reported current ratio of 8.1× in Q1 2026.
How has AARD's current ratio changed year-over-year?
AARD's current ratio decreased by 68.8% year-over-year, from 25.9× to 8.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.